Is It Too Late to Buy Palantir Stock?

Palantir (PLTR) reported robust Q3 results, with revenue surging 63% to $1.181 billion, significantly exceeding guidance, driven by a 121% increase in U.S. commercial revenue and 55% growth in government segments. Despite these strong operational achievements, the stock declined post-earnings, as the article highlights its extreme valuation at 140 times sales and 223 times 2026 earnings. Analysis suggests that even aggressive future growth projections are already priced into its current $452 billion market capitalization, implying limited upside and potentially flat returns for investors over the next five years, making it an unfavorable buy at present levels.

Analysis

Palantir (PLTR) reported robust Q3 results, with revenue surging 63% year-over-year to $1.181 billion, significantly exceeding its $1.085 billion guidance. This strong performance was driven by a 121% increase in U.S. commercial revenue to $397 million and 55% growth in government revenue. Despite these "blowout" operational achievements, the stock experienced a decline post-earnings, signaling investor concerns beyond fundamental growth.

The article highlights Palantir's extreme valuation, trading at 140 times sales and 223 times 2026 earnings, indicating substantial future growth is already priced in. Even assuming an aggressive 50% compound annual growth rate over the next five years, the projected $9.1 billion in profits (at a 35% margin) would only justify a market cap of $457 billion at a 50x trailing earnings multiple. This implies a nearly flat return over a five-year horizon from its current $452 billion market capitalization.

This valuation suggests that Palantir's stock has become disconnected from its underlying business success, with current prices baking in years of anticipated growth. The high premium creates a scenario where the company must consistently and massively exceed already elevated expectations to justify its current price. Any deviation, such as a single "bad earnings report," could lead to a significant correction, posing considerable risk to investors at these levels.

Key Decisions for Investors

• Investors should critically assess Palantir's extreme valuation multiples (140x sales, 223x 2026 earnings) against its strong operational growth, recognizing that significant future performance is already priced in.
• Given the high expectations, investors should closely monitor Palantir's ability to consistently exceed guidance and maintain its high growth trajectory, as any miss could trigger a sharp stock correction.
• The current market capitalization implies limited upside and potentially flat returns over a five-year horizon, suggesting a less favorable risk/reward profile for new investments at these elevated levels.